BENZYLIDENE- AND CINNAMYLIDENE-ANABASEINES AS NEURONAL NICOTINIC alpha7 RECEPTOR AGONIST

摘要

PPROBLEM TO BE SOLVED: To provide compositions for benzylidene- and cinnamylidene-anabaseines and methods for using these compositions for treating conditions associated with defects or malfunctioning of nicotinic subtypes brain receptors. PSOLUTION: This invention relates to compositions for benzylidene- and cinnamylidene-anabaseines and methods for using these compositions for treating conditions associated with defects or malfunctioning of nicotinic subtypes brain receptors. These compositions target the 7 receptor subtype with little or no activation of the 42 or other receptor subtypes. PCOPYRIGHT: (C)2010,JPO&INPIT